Search Results for: INMB

INmune Bio (NASDAQ: INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, this morning announced that it will attend the BIO CEO & Investor Conference taking place February 11-12 at the New York Marriott Marquis in New York City. R.J. Tesi, M.D., president and chief executive … Continue reading “NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at the BIO CEO & Investor Conference in New York City”

INmune Bio (NASDAQ: INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, this morning announced that its common stock is expected to begin trading under the ticker symbol “INMB” on The Nasdaq Capital Market today. Per the update, the company closed its initial public offering (“IPO”) … Continue reading “NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Closes IPO; Begins Trading on the Nasdaq Capital Market”